Proprietary AI analyst is now available
- Public Comps
- Cencora
Cencora Valuation Multiples
Discover Cencora's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Fastenal, Cardinal Health, Grainger, Sumitomo and more.
Cencora Overview
About Cencora
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Founded
2001
HQ

Employees
51.0K
Website
Sectors
Financials (LTM)
EV
$65B
Valuation Multiples
Start free trialCencora Financials
Cencora reported last 12-month revenue of $333B and EBITDA of $5B.
In the same LTM period, Cencora generated $12B in gross profit, $5B in EBITDA, and $3B in net income.
Revenue (LTM)
Cencora P&L
In the most recent fiscal year, Cencora reported revenue of $321B and EBITDA of $5B.
Cencora is profitable as of last fiscal year, with gross margin of 4%, EBITDA margin of 1%, and net margin of 1%.
Financial data powered by Morningstar, Inc.
Cencora Stock Performance
Cencora has current market cap of $55B, and enterprise value of $65B.
Market Cap Evolution
Cencora's stock price is $281.67.
Cencora share price increased by 4.6% in the last 30 days, and decreased by 6.1% in the last year.
Cencora has an EPS (earnings per share) of $16.05.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $65B | $55B | 0.0% | 4.6% | -10.3% | -6.1% | $16.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCencora Valuation Multiples
Cencora trades at 0.2x EV/Revenue multiple, and 12.7x EV/EBITDA.
EV / Revenue (LTM)
Cencora Financial Valuation Multiples
As of June 15, 2026, Cencora has market cap of $55B and EV of $65B.
Cencora has a P/E ratio of 16.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cencora Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Cencora Margins & Growth Rates
Cencora grew revenue by 5% and EBITDA by 12% in the last fiscal year.
In the most recent fiscal year, Cencora reported gross margin of 4%, EBITDA margin of 1%, and net margin of 1%.
Cencora Margins
Cencora Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Cencora Operational KPIs
Cencora's revenue per employee in the last FY averaged $6.3M, while opex per employee averaged $0.1M for the same period.
Cencora's Rule of 40 is 7% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cencora's Rule of X is 15% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Cencora Competitors
Cencora competitors include Fastenal, Cardinal Health, Grainger, Sumitomo, Rheinmetall, Ferguson, Sysco, Bunge, US Foods and Bollore.
Most Cencora public comparables operate across Wholesale Distribution.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 6.5x | 6.2x | 29.1x | 27.7x | |||
| 0.3x | 0.2x | 18.0x | 14.4x | |||
| 3.6x | 3.4x | 21.8x | 20.5x | |||
| 1.4x | 1.4x | 10.3x | 15.9x | |||
| 5.7x | 4.8x | 25.1x | 21.1x | |||
| 1.6x | 1.6x | 16.7x | 15.7x | |||
| 0.6x | 0.6x | 11.9x | 11.7x | |||
| 0.6x | 0.5x | 14.7x | 12.2x | |||
This data is available for Pro users. Sign up to see all Cencora competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Cencora
Cencora has acquired 10 companies to date.
Last acquisition by Cencora was on March 22nd 2026. Cencora acquired EyeSouth (retina unit) for $1B (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Cencora
| Description | EyeSouth (retina unit) runs a network of physician-led ophthalmology practices treating retinal conditions like macular degeneration and diabetic retinopathy. Specialists provide diagnostic imaging, surgery, and monitoring, supported by shared billing, compliance, and operations. Network practices access clinical trials and advanced therapies. | - | NextPharma Logistics is a temperature-controlled logistics provider for pharmaceuticals, handling warehousing, order fulfillment, project distribution, and returns management. Its GDP-compliant facilities in Europe store products from 2-8°C to 15-25°C with real-time tracking via SAP. Monthey-headquartered in Switzerland, it supports clinical trials and commercial supply chains for clients like Roche. | Retina Consultants of America is a management organization uniting over 200 retinal specialists across 18 states. The network provides practice management, clinical research support, and access to therapies for macular degeneration, retinal vein occlusions, and diabetic eye disease. Headquartered in New York, it facilitates physician collaboration on innovative treatments. | |
| HQ Country | - | ||||
| HQ City | - | - | Bielefeld | Dallas, TX | |
| Deal Date | 22 Mar 2026 | 12 Dec 2025 | 12 Oct 2025 | 6 Nov 2024 | |
| Valuation | $1B | $11B | undisclosed | $5B | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Cencora acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Investments by Cencora
Cencora has invested in 2 companies to date.
Latest investment by Cencora was on September 13th 2023. Cencora invested in Sempre Health in their $20M Series C round (EV/Revenue multiple available to Pro users).
Latest Investments by Cencora
| Description | Sempre Health is a healthcare technology company introducing dynamic pricing for prescriptions nationwide. By analyzing millions of records to predict patient behaviors, it sends personalized price offers via text to pharmacies, lowering costs, extending affordability, and improving outcomes while building datasets on price sensitivities. | - | - |
| HQ Country | |||
| HQ City | San Francisco, CA | Somerset, NJ | Somerset, NJ |
| Deal Date | 13 Sep 2023 | 25 Oct 2022 | 14 Dec 2021 |
| Round | Series C | Series A | Series A |
| Raised | $20M | $6M | $8M |
| Investors | Cencora; Echo Health Ventures; Industry Ventures; The Blue Venture Fund; UPMC Enterprises | Cencora; Healthy Ventures; Shanda Group; Vertical Venture Partners | Cencora; Shanda Group; Vertical Venture Partners |
| Valuation | undisclosed | undisclosed | undisclosed |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Cencora investments and their VC round multiples. Start Free Trial | |||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cencora
| When was Cencora founded? | Cencora was founded in 2001. |
| Where is Cencora headquartered? | Cencora is headquartered in United States. |
| How many employees does Cencora have? | As of today, Cencora has over 51K employees. |
| Who is the CEO of Cencora? | Cencora's CEO is Robert P. Mauch. |
| Is Cencora publicly listed? | Yes, Cencora is a public company listed on NYSE. |
| What is the stock symbol of Cencora? | Cencora trades under COR ticker. |
| When did Cencora go public? | Cencora went public in 1995. |
| Who are competitors of Cencora? | Cencora main competitors include Fastenal, Cardinal Health, Grainger, Sumitomo, Rheinmetall, Ferguson, Sysco, Bunge, US Foods, Bollore. |
| What is the current market cap of Cencora? | Cencora's current market cap is $55B. |
| What is the current revenue of Cencora? | Cencora's last 12 months revenue is $333B. |
| What is the current revenue growth of Cencora? | Cencora revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Cencora? | Current revenue multiple of Cencora is 0.2x. |
| What is the current EBITDA of Cencora? | Cencora's last 12 months EBITDA is $5B. |
| What is Cencora's EBITDA margin? | Cencora's last 12 months EBITDA margin is 2%. |
| What is the current EV/EBITDA multiple of Cencora? | Current EBITDA multiple of Cencora is 12.7x. |
| What is the current FCF of Cencora? | Cencora's last 12 months FCF is $3B. |
| What is Cencora's FCF margin? | Cencora's last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of Cencora? | Current FCF multiple of Cencora is 21.2x. |
| How many companies Cencora has acquired to date? | As of June 2026, Cencora has acquired 10 companies. |
| What was the largest acquisition by Cencora? | $11B acquisition of OneOncology on 12th December 2025 was the largest M&A Cencora has done to date. |
| What companies Cencora acquired? | Cencora acquired OneOncology, Alliance Healthcare, Retina Consultants of America, PharMEDium Healthcare, MWI Veterinary Supply, PharmaLex, EyeSouth (retina unit), H. D. Smith, St. Francis Group, and NextPharma Logistics. |
| In how many companies Cencora has invested to date? | As of June 2026, Cencora has invested in 2 companies. |
| What was the last Cencora investment? | On 13th September 2023 Cencora invested in Sempre Health, participating in a $20M Series C round, alongside Echo Health Ventures, Industry Ventures, The Blue Venture Fund, and UPMC Enterprises. |
| In what companies Cencora invested in? | Cencora invested in Sempre Health and WhizAI. |
See public comps similar to Cencora
Lists including Cencora
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

